Timothy M. Shannon, Director at CytomX Therapeutics, Inc. (CTMX), sold 50,164 shares at $10.60 ($532K) on 2016-05-27, disclosed to the SEC on 2016-06-01.
Open-market sale of $532k CTMX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.60 | 25,082 | $266K | 50.0% |
| 2 | $10.60 | 25,082 | $266K | 50.0% |
| Total | $10.60 avg | 50,164 | $532K | 100% |
| Filing → |
| ARVN | SELL | 2021-09-27 | $4.3M | — | Filing → |
| ARVN | SELL | 2021-09-27 | $32.9M | — | Filing → |
| RLYB | BUY | 2021-08-04 | $1000K | — | Filing → |